You are here

formularies

The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars

Drug Channels

Wed, 01/22/25 - 11:17 am

Express Scripts

The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup

Drug Channels

Tue, 01/9/24 - 09:41 am

Express Scripts

The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars

Drug Channels

Tue, 01/10/23 - 10:44 am

Express Scripts

CVS re-adds BMS, Pfizer's Eliquis to formulary after tough negotiations, patient pushback

Fierce Pharma

Fri, 06/24/22 - 10:42 am

Bristol Myers Squibb

Five Takeaways from the Big Three PBMs’ 2022 Formulary Exclusions

Drug Channels

Wed, 01/19/22 - 10:58 am

Express Scripts